While the study only involved narcolepsy type 1, previous work has shown that orexin signaling may be deficient in other ...

To know whether you have narcolepsy, it's important to recognize a few common symptoms, such as excessive daytime sleepiness.

Alkermes has reached an agreement to buy Avadel Pharma in a deal valued at up to $2.1 billion, claiming rights to an ...

Analysts called the proposed purchase of Avadel Pharmaceuticals a “clear” strategic fit for Alkermes, handing it an already marketed product for excessive daytime sleepiness.

When entrepreneur and author Michelle Weger first started falling asleep in her university classrooms at 17, the teenager who ...

Brain clearance involves three types of pulsation: cardiovascular pulsations generated by the heartbeat in the arteries, respiratory pulsations in the veins and cerebrospinal fluid spaces, and slow ...

CAMAS, Wash., Aug. 4, 2025 /PRNewswire-PRWeb/ -- Narcolepsy Network is pleased to introduce The Listening Project, an initiative providing biopharmaceutical companies with unprecedented equal access ...

Takeda and Alkermes both took data from their orexin receptor 2 (OX2R)-selective agonists to Singapore this morning as the race to get a new class of narcolepsy drugs approved heats up. Takeda ...

A hormone produced by the brain, orexin, may play a central role in the functioning of the brain’s glymphatic system, which clears waste, according to a new study from the University of Oulu.

CHRISTUS Health in Shreveport has opened a new state-of-the-art sleep lab to support early detection and treatment of ...

Sleep paralysis is common, and rarely harmful, though it can be scary. Here's what you should know about the causes, risk ...

Alkermes acquires Avadel for $2.1 billion, enhancing its sleep medicine market presence and commercial portfolio with Lumryz. The acquisition supports Alkermes' development pipeline for central ...